Tuberculist information
Gene namepknG
Protein functionSerine/threonine-protein kinase PknG (protein kinase G) (STPK G)
Functional category(tuberculist)regulatory proteins
Gene location(kb)495.062
Molecular mass(da)81577.4
External sites TB Database TubercuList WebTB
Protein sequence
Number of amino acids : 750
	  		  	1    MAKASETERSGPGTQPADAQTATSATVRPLSTQAVFRPDFGDEDNFPHPTLGPDTEPQDR   60
			  	61   MATTSRVRPPVRRLGGGLVEIPRAPDIDPLEALMTNPVVPESKRFCWNCGRPVGRSDSET  120
			  	121  KGASEGWCPYCGSPYSFLPQLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVL  180
			  	181  KGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL  240
			  	241  KRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRI  300
			  	301  NSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVL  360
			  	361  KTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIFSPSRS  420
			  	421  TFGVDLLVAHTDVYLDGQVHAEKLTANEIVTALSVPLVDPTDVAASVLQATVLSQPVQTL  480
			  	481  DSLRAARHGALDADGVDFSESVELPLMEVRALLDLGDVAKATRKLDDLAERVGWRWRLVW  540
			  	541  YRAVAELLTGDYDSATKHFTEVLDTFPGELAPKLALAATAELAGNTDEHKFYQTVWSTND  600
			  	601  GVISAAFGLARARSAEGDRVGAVRTLDEVPPTSRHFTTARLTSAVTLLSGRSTSEVTEEQ  660
			  	661  IRDAARRVEALPPTEPRVLQIRALVLGGALDWLKDNKASTNHILGFPFTSHGLRLGVEAS  720
			  	721  LRSLARVAPTQRHRYTLVDMANKVRPTSTF
			  			

Known structures in the PDB
PDB ID2PZI
Total residue count1362
Number of chains2
MethodX-RAY
Resolution2.4
Profile-based domain assignment
Structural/Functional domain familyPfam acc.no./SCOP IDDomain Region
PkinasePF00069151-403
Mtb Structural Proteome models
Model Number1
Model nameRv0410c_2pzi_A
Template2PZI    APDBCREDO
Template coverage69_746
Template Identity(%)100.0
Model coverage(%)90.3
Normalized DOPE score-1.361

Model Number2
Model nameRv0410c.6
Template2AVP    APDBCREDO
Template coverage1_68
Template Identity(%)16.2
Model coverage(%)9.5
Normalized DOPE score-0.757

Model Number3
Model nameRv0410c.5
Template2FO7    APDBCREDO
Template coverage9_134
Template Identity(%)20.0
Model coverage(%)16.5
Normalized DOPE score-0.479

Model Number4
Model nameRv0410c.2
Template1K9A    APDBCREDO
Template coverage52_442
Template Identity(%)16.1
Model coverage(%)51.1
Normalized DOPE score0.067

Model Number5
Model nameRv0410c
Template2ACX    APDBCREDO
Template coverage93_451
Template Identity(%)23.2
Model coverage(%)45.3
Normalized DOPE score0.08

Model Number6
Model nameRv0410c.1
Template1OPK    APDBCREDO
Template coverage122_511
Template Identity(%)15.9
Model coverage(%)51.1
Normalized DOPE score0.389

Structure Models from Chopin
Model Number1
Profile1.10.510.10
Click for model details
zscore13.93
Residue begin183
Residue end536
Model Number2
Profiled.144.1.9
Click for model details
zscore10.49
Residue begin150
Residue end337
Model Number3
Profiled.144.1.7
Click for model details
zscore9.31
Residue begin1
Residue end703
Binding pockets
STRING
Cytoscape Web will replace the contents of this div with protein-protein interaction network.
Protein interacting with Rv0410cGene nameConfidence Score
Rv0412cRv0412c0.99
Rv0411cglnH0.976
Rv0018cpstP0.94
Rv1747Rv17470.91
Rv1747Rv17470.91
Rv1747Rv17470.91
Potential ligand/drug binding sites
Protein ModelPocket NumberDrug Binding Site PMIN ScorePvalue PMINPMAX ScorePvalue PMAX
Rv0410c.251uwj_BAX_A_1723PDBCREDO0.6140.1630.6140.002
Rv0410c.2121uwj_BAX_B_1723PDBCREDO0.6300.1440.6120.002
Rv0410c.2121uwh_BAX_B_1723PDBCREDO0.6290.1460.6100.002
Rv0410c.2121uwh_BAX_A_1723PDBCREDO0.6280.1470.6100.002
Rv0410c.2121uob_PNN_A_1311PDBCREDO0.6090.1680.6090.002
Rv0410c.1102hyy_STI_D_600PDBCREDO0.6260.1490.6080.002
Rv0410c_2pzi_A91hwi_115_A_2PDBCREDO0.6070.1710.6070.002
Rv0410c.2121uwj_BAX_A_1723PDBCREDO0.6810.0960.6060.002
Rv0410c_2pzi_A93ut5_LOC_D_502PDBCREDO0.6670.1090.6050.002
Rv0410c.1102hyy_STI_A_600PDBCREDO0.6230.1530.6050.002
Rv0410c.1103pyy_STI_A_3PDBCREDO0.6210.1540.6040.002
Rv0410c.1101iep_STI_B_202PDBCREDO0.6210.1550.6030.002
Rv0410c.1101iep_STI_A_201PDBCREDO0.6210.1550.6030.002
Rv0410c.1103k5v_STI_B_2PDBCREDO0.6200.1560.6020.002
Rv0410c.1103mss_STI_C_1PDBCREDO0.6190.1570.6020.002
Rv0410c.1103pyy_STI_B_4PDBCREDO0.6190.1580.6010.002
Rv0410c.1102hyy_STI_C_600PDBCREDO0.6180.1580.6000.002
Rv0410c.1103ms9_STI_A_1PDBCREDO0.6170.1590.6000.002
Rv0410c.1103ms9_STI_B_1PDBCREDO0.6170.1590.5990.002
Rv0410c.1103mss_STI_A_1PDBCREDO0.6170.1590.5990.002
Rv0410c.1103mss_STI_D_1PDBCREDO0.6150.1610.5980.002
Rv0410c.1103mss_STI_B_1PDBCREDO0.6130.1640.5950.002
Rv0410c.1103gvu_STI_A_1001PDBCREDO0.6130.1640.5950.002
Rv0410c_2pzi_A93ut5_LOC_B_502PDBCREDO0.6970.0830.5940.002
Rv0410c.2124asd_BAX_A_1500PDBCREDO0.6110.1670.5930.002
Rv0410c_2pzi_A91lhv_NOG_A_301PDBCREDO0.6320.1430.5920.002
Rv0410c.253d91_REM_A_350PDBCREDO0.6460.1280.5920.002
Rv0410c.253d91_REM_B_350PDBCREDO0.6360.1390.5830.003
Rv0410c_2pzi_A91jg2_ADN_A_500PDBCREDO0.6440.1300.5820.003
Rv0410c.251uwj_BAX_B_1723PDBCREDO0.6320.1430.5790.003
Rv0410c.251uwh_BAX_B_1723PDBCREDO0.6700.1050.5790.003
Rv0410c.251uwh_BAX_A_1723PDBCREDO0.6690.1060.5780.003
Rv0410c.253pww_ROC_A_1001PDBCREDO0.6610.1140.5760.003
Rv0410c.2121y0x_T44_X_500PDBCREDO0.5930.1880.5750.003
Rv0410c.1103k5v_STI_A_2PDBCREDO0.6260.1490.5750.003
Rv0410c_2pzi_A93tkd_CYZ_A_266PDBCREDO0.6290.1460.5710.004
Rv0410c.1101uwj_BAX_B_1723PDBCREDO0.5870.1950.5700.004
Rv0410c_2pzi_A92xpv_MIY_A_1209PDBCREDO0.6520.1220.5690.004
Rv0410c.1102hyy_STI_B_600PDBCREDO0.6030.1750.5690.004
Rv0410c.2122hyy_STI_B_600PDBCREDO0.5680.2190.5680.004
Rv0410c.2123tne_RIT_A_401PDBCREDO0.6230.1530.5680.004
Rv0410c.1103oez_STI_A_601PDBCREDO0.5840.1980.5680.004
Rv0410c.2123uvv_T3_A_501PDBCREDO0.6430.1320.5680.004
Rv0410c.1101opj_STI_A_3PDBCREDO0.6350.1400.5670.004
Rv0410c.253mss_STI_B_1PDBCREDO0.5830.2000.5660.004
Rv0410c.253gvu_STI_A_1001PDBCREDO0.5810.2020.5650.004
Rv0410c.253mss_STI_A_1PDBCREDO0.5810.2030.5650.004
Rv0410c.2122y6o_1N1_A_1892PDBCREDO0.6390.1350.5640.004
Rv0410c.1101opj_STI_B_4PDBCREDO0.6320.1430.5640.004
Rv0410c.253k5v_STI_B_2PDBCREDO0.5810.2030.5640.004
Rv0410c.253pyy_STI_A_3PDBCREDO0.5810.2030.5640.004
Rv0410c.251iep_STI_B_202PDBCREDO0.5800.2040.5640.004
Rv0410c.253ms9_STI_B_1PDBCREDO0.5800.2040.5640.004
Rv0410c.253mss_STI_C_1PDBCREDO0.5800.2040.5640.004
Rv0410c.253mss_STI_D_1PDBCREDO0.5800.2040.5640.004
Rv0410c_2pzi_A21kij_NOV_A_400PDBCREDO0.5630.2260.5630.004
Rv0410c.253ms9_STI_A_1PDBCREDO0.5800.2040.5630.004
Rv0410c.2121z2b_VLB_C_800PDBCREDO0.5630.2270.5630.004
Rv0410c.2121bsx_T3_A_1PDBCREDO0.6570.1180.5620.004
Rv0410c.2121bsx_T3_B_2PDBCREDO0.6570.1180.5620.004
Rv0410c.251iep_STI_A_201PDBCREDO0.5770.2070.5610.004
Rv0410c.252hyy_STI_C_600PDBCREDO0.5770.2070.5610.004
Rv0410c.2121xzx_T3_X_500PDBCREDO0.6340.1400.5600.004
Rv0410c.253k5v_STI_A_2PDBCREDO0.5760.2090.5600.004
Rv0410c.1103nxu_RIT_A_600PDBCREDO0.6450.1300.5600.004
Rv0410c.252hyy_STI_D_600PDBCREDO0.5760.2090.5600.004
Rv0410c.252hyy_STI_A_600PDBCREDO0.5760.2090.5590.004
Rv0410c.2123gws_T3_X_500PDBCREDO0.6540.1210.5590.004
Rv0410c.2123heg_BAX_A_1PDBCREDO0.5580.2330.5580.004
Rv0410c.253pyy_STI_B_4PDBCREDO0.5730.2120.5570.004
Rv0410c.1103cs9_NIL_A_600PDBCREDO0.6240.1520.5570.004
Rv0410c.1102pl0_STI_A_200PDBCREDO0.5910.1900.5570.004
Rv0410c.2402wek_DIF_B_1376PDBCREDO0.6050.1730.5570.004
Rv0410c.1103nxu_RIT_B_600PDBCREDO0.6410.1340.5560.004
Rv0410c.2122oiq_STI_A_1001PDBCREDO0.5560.2350.5560.005
Rv0410c.1101uwj_BAX_A_1723PDBCREDO0.5890.1930.5560.005
Rv0410c_2pzi_A91hwi_115_D_3PDBCREDO0.6120.1650.5560.005
Rv0410c.1104asd_BAX_A_1500PDBCREDO0.5720.2140.5550.005
Rv0410c.1102oiq_STI_A_1001PDBCREDO0.5880.1930.5550.005
Rv0410c.2123tkd_CYZ_B_267PDBCREDO0.5710.2160.5540.005
Rv0410c_2pzi_A93tne_RIT_A_401PDBCREDO0.6090.1680.5530.005
Rv0410c.251z2b_VLB_C_800PDBCREDO0.6210.1540.5530.005
Rv0410c_2pzi_A91jg3_ADN_A_500PDBCREDO0.6810.0960.5520.005
Rv0410c_2pzi_A93tkd_CYZ_B_267PDBCREDO0.6480.1270.5520.005
Rv0410c_2pzi_A91hwl_FBI_D_3PDBCREDO0.6670.1080.5520.005
Rv0410c_2pzi_A91hwi_115_B_1PDBCREDO0.6080.1690.5520.005
Rv0410c.253nxu_RIT_A_600PDBCREDO0.5990.1800.5510.005
Rv0410c_2pzi_A91sa1_POD_D_701PDBCREDO0.6660.1100.5510.005
Rv0410c.1103cs9_NIL_B_600PDBCREDO0.6330.1420.5500.005
Rv0410c_2pzi_A92nni_MTK_A_501PDBCREDO0.7040.0780.5490.005
Rv0410c.251opj_STI_B_4PDBCREDO0.5800.2030.5490.005
Rv0410c.2121hwl_FBI_D_3PDBCREDO0.5490.2460.5490.005
Rv0410c.253oez_STI_A_601PDBCREDO0.5640.2240.5480.005
Rv0410c.253q70_RIT_A_2001PDBCREDO0.6160.1600.5480.005
Rv0410c.2121hwl_FBI_B_1PDBCREDO0.5480.2470.5480.005
Rv0410c_2pzi_A91hwl_FBI_B_1PDBCREDO0.6620.1130.5480.005
Rv0410c.253nxu_RIT_B_600PDBCREDO0.5960.1840.5480.005
Rv0410c.2123tne_RIT_B_401PDBCREDO0.6010.1780.5480.005
Rv0410c_2pzi_A91hwk_117_D_3PDBCREDO0.6420.1330.5470.005
Rv0410c.252x9g_LYA_A_1270PDBCREDO0.6960.0840.5470.005
Rv0410c.251opj_STI_A_3PDBCREDO0.5790.2050.5470.005
Rv0410c_2pzi_A91hwi_115_C_4PDBCREDO0.6040.1740.5460.005
Rv0410c.254asd_BAX_A_1500PDBCREDO0.5950.1850.5460.005
Rv0410c.1101uwh_BAX_A_1723PDBCREDO0.5960.1830.5450.005
Rv0410c.1101uwh_BAX_B_1723PDBCREDO0.5960.1840.5450.005
Rv0410c.251t46_STI_A_3PDBCREDO0.6250.1510.5450.005
Rv0410c.1103cs9_NIL_D_600PDBCREDO0.6610.1140.5440.006
Rv0410c.2121hwk_117_B_1PDBCREDO0.5930.1880.5430.006
Rv0410c.1103cs9_NIL_C_600PDBCREDO0.6590.1150.5430.006
Rv0410c_2pzi_A91sa1_POD_B_700PDBCREDO0.6750.1010.5430.006
Rv0410c_2pzi_A93ri5_IVM_C_350PDBCREDO0.6440.1300.5420.006
Rv0410c_2pzi_A91hwl_FBI_C_4PDBCREDO0.6550.1200.5420.006
Rv0410c_2pzi_A93rif_IVM_B_403PDBCREDO0.6440.1310.5420.006
Rv0410c.2121t46_STI_A_3PDBCREDO0.6970.0830.5410.006
Rv0410c.2122pl0_STI_A_200PDBCREDO0.5400.2570.5400.006
Rv0410c.2123oez_STI_B_601PDBCREDO0.5930.1880.5400.006
Rv0410c_2pzi_A91hwl_FBI_A_2PDBCREDO0.6530.1210.5400.006
Rv0410c_2pzi_A93rif_IVM_A_402PDBCREDO0.6420.1320.5400.006
Rv0410c_2pzi_A93rif_IVM_D_402PDBCREDO0.6420.1320.5400.006
Rv0410c.2121hwl_FBI_C_4PDBCREDO0.5400.2580.5400.006
Rv0410c.2123gcs_BAX_A_401PDBCREDO0.5560.2360.5400.006
Rv0410c.2121hwl_FBI_A_2PDBCREDO0.5390.2590.5390.006
Rv0410c.2122h79_T3_A_1PDBCREDO0.6510.1230.5390.006
Rv0410c.2122hw2_RFP_A_1200PDBCREDO0.5910.1900.5390.006
Rv0410c.2123frq_ERY_B_195PDBCREDO0.5910.1900.5390.006
Rv0410c.2123k5v_STI_B_2PDBCREDO0.5880.1940.5380.006
Rv0410c.2122hyy_STI_A_600PDBCREDO0.5880.1940.5380.006
Rv0410c.2123ms9_STI_B_1PDBCREDO0.5880.1940.5380.006
Rv0410c_2pzi_A92aa5_STR_A_301PDBCREDO0.5380.2610.5380.006
Rv0410c_2pzi_A93n58_ADN_A_500PDBCREDO0.6170.1600.5380.006
Rv0410c_2pzi_A93e22_LOC_D_700PDBCREDO0.5920.1880.5380.006
Rv0410c_2pzi_A93ria_IVM_C_349PDBCREDO0.6380.1360.5370.006
Rv0410c_2pzi_A93spk_TPV_A_100PDBCREDO0.5550.2370.5370.006
Rv0410c.2123ms9_STI_A_1PDBCREDO0.5860.1970.5360.006
Rv0410c.2123pyy_STI_A_3PDBCREDO0.5860.1970.5360.006
Rv0410c.2123pyy_STI_B_4PDBCREDO0.5860.1970.5360.006
Rv0410c_2pzi_A93e22_LOC_B_700PDBCREDO0.5910.1900.5360.006
Rv0410c.2121hwk_117_A_2PDBCREDO0.5520.2410.5360.006
Rv0410c.2121lhv_NOG_A_301PDBCREDO0.6070.1710.5360.006
Rv0410c.252hyy_STI_B_600PDBCREDO0.6020.1770.5360.006
Rv0410c_2pzi_A93rif_IVM_A_403PDBCREDO0.6360.1380.5360.006
Rv0410c.2121hwk_117_C_4PDBCREDO0.5510.2420.5350.006
Rv0410c.2123mss_STI_B_1PDBCREDO0.5840.1980.5350.006
Rv0410c.2121iep_STI_A_201PDBCREDO0.5840.1990.5350.006
Rv0410c_2pzi_A92aa5_STR_B_302PDBCREDO0.5340.2660.5340.006
Rv0410c.2122hyy_STI_C_600PDBCREDO0.5830.1990.5340.006
Rv0410c.2123mss_STI_A_1PDBCREDO0.5830.1990.5340.006
Rv0410c.2123gvu_STI_A_1001PDBCREDO0.5830.2000.5340.006
Rv0410c_2pzi_A22ya7_ZMR_B_1776PDBCREDO0.5340.2670.5340.007
Rv0410c.253cs9_NIL_A_600PDBCREDO0.5640.2250.5330.007
Rv0410c_2pzi_A91lhu_EST_A_301PDBCREDO0.6120.1650.5330.007
Rv0410c.2123tkd_CYZ_A_266PDBCREDO0.5850.1980.5330.007
Rv0410c.253tne_RIT_A_401PDBCREDO0.6570.1170.5330.007
Rv0410c.2123mss_STI_C_1PDBCREDO0.5820.2010.5330.007
Rv0410c.2121hwi_115_B_1PDBCREDO0.5840.1990.5320.007
Rv0410c.2123mss_STI_D_1PDBCREDO0.5810.2020.5320.007
Rv0410c.2123oez_STI_A_601PDBCREDO0.5810.2020.5320.007
Rv0410c.2123b0w_DGX_A_1PDBCREDO0.5480.2470.5320.007
Rv0410c.2121sa1_POD_B_700PDBCREDO0.5480.2470.5320.007
Rv0410c.1103rgf_BAX_A_465PDBCREDO0.5630.2260.5320.007
Rv0410c_2pzi_A22ya7_ZMR_A_1776PDBCREDO0.5310.2710.5310.007
Rv0410c_2pzi_A91hwk_117_B_1PDBCREDO0.7010.0800.5310.007
Rv0410c.2121hwi_115_D_3PDBCREDO0.5820.2010.5310.007
Rv0410c.252pl0_STI_A_200PDBCREDO0.5970.1830.5310.007
Rv0410c_2pzi_A94e3a_ADN_B_500PDBCREDO0.6790.0980.5310.007
Rv0410c.252qxs_RAL_B_600PDBCREDO0.5770.2080.5310.007
Rv0410c.2121hwk_117_D_3PDBCREDO0.5470.2480.5310.007
Rv0410c.2121iep_STI_B_202PDBCREDO0.5790.2050.5300.007
Rv0410c.2122hyy_STI_D_600PDBCREDO0.5790.2050.5300.007
Rv0410c.252qxs_RAL_A_600PDBCREDO0.5760.2090.5300.007
Rv0410c_2pzi_A93bbt_FMM_D_91PDBCREDO0.5660.2220.5300.007
Rv0410c.2122h77_T3_A_1PDBCREDO0.6610.1140.5290.007
Rv0410c_2pzi_A91hwk_117_C_4PDBCREDO0.6580.1160.5290.007
Rv0410c.1103oez_STI_B_601PDBCREDO0.6150.1620.5280.007
Rv0410c.252vn1_FK5_A_501PDBCREDO0.5580.2330.5280.007
Rv0410c_2pzi_A21a4l_DCF_B_853PDBCREDO0.5860.1960.5280.007
Rv0410c.253b0w_DGX_B_1PDBCREDO0.5420.2550.5270.007
Rv0410c.2123b0w_DGX_B_1PDBCREDO0.6100.1680.5270.007
Rv0410c_2pzi_A91hwk_117_A_2PDBCREDO0.6560.1180.5270.007
Rv0410c_2pzi_A93tne_RIT_B_401PDBCREDO0.5800.2030.5270.007
Rv0410c.2121sa1_POD_D_701PDBCREDO0.5260.2780.5260.007
Rv0410c_2pzi_A21a4l_DCF_C_1353PDBCREDO0.5840.1990.5250.007
Rv0410c_2pzi_A93ri5_IVM_B_349PDBCREDO0.6970.0830.5250.007
Rv0410c.2122fum_MIX_D_3539PDBCREDO0.6780.0990.5250.007
Rv0410c.253rgf_BAX_A_465PDBCREDO0.5240.2810.5240.008
Rv0410c_2pzi_A21a4l_DCF_D_1853PDBCREDO0.5820.2010.5240.008
Rv0410c_2pzi_A91jg3_ADN_B_550PDBCREDO0.7230.0640.5240.008
Rv0410c_2pzi_A93ri5_IVM_D_349PDBCREDO0.6960.0840.5240.008
Rv0410c.1102vn1_FK5_A_501PDBCREDO0.5870.1950.5240.008
Rv0410c_2pzi_A22ya7_ZMR_C_1776PDBCREDO0.5240.2820.5240.008
Rv0410c_2pzi_A93rif_IVM_E_402PDBCREDO0.6950.0850.5230.008
Rv0410c.2123hec_STI_A_1PDBCREDO0.5740.2120.5230.008
Rv0410c_2pzi_A21a4l_DCF_A_353PDBCREDO0.5810.2030.5230.008
Rv0410c.2123frq_ERY_A_195PDBCREDO0.5540.2380.5220.008
Rv0410c_2pzi_A93d91_REM_A_350PDBCREDO0.6500.1250.5220.008
Rv0410c_2pzi_A91oq5_CEL_A_701PDBCREDO0.6200.1560.5220.008
Rv0410c_2pzi_A93rhw_IVM_B_348PDBCREDO0.6930.0860.5220.008
Rv0410c_2pzi_A93rhw_IVM_D_348PDBCREDO0.6930.0860.5220.008
Rv0410c_2pzi_A93ria_IVM_A_348PDBCREDO0.6930.0860.5220.008
Rv0410c.253cs9_NIL_C_600PDBCREDO0.5980.1810.5220.008
Rv0410c.253cs9_NIL_D_600PDBCREDO0.5980.1810.5220.008
Rv0410c.253cs9_NIL_B_600PDBCREDO0.5670.2210.5220.008
Rv0410c.253prs_RIT_A_1001PDBCREDO0.6970.0830.5220.008
Rv0410c_2pzi_A93ria_IVM_C_350PDBCREDO0.6920.0870.5210.008
Rv0410c.252v0z_C41_O_1327PDBCREDO0.6130.1630.5210.008
Rv0410c.2121fm6_BRL_X_504PDBCREDO0.5890.1920.5210.008
Rv0410c.253b0w_DGX_A_1PDBCREDO0.5680.2200.5200.008
Rv0410c_2pzi_A93rhw_IVM_D_349PDBCREDO0.6910.0880.5200.008
Rv0410c.1101err_RAL_B_600PDBCREDO0.5870.1950.5200.008
Rv0410c_2pzi_A93rhw_IVM_B_349PDBCREDO0.6900.0880.5200.008
Rv0410c_2pzi_A93frq_ERY_B_195PDBCREDO0.5720.2140.5190.008
Rv0410c.2121xkk_FMM_A_91PDBCREDO0.7050.0770.5190.008
Rv0410c_2pzi_A93ria_IVM_E_348PDBCREDO0.6890.0890.5190.008
Rv0410c.2123d91_REM_B_350PDBCREDO0.5350.2660.5190.008
Rv0410c.1124eyb_0WO_A_303PDBCREDO0.5790.2060.5190.008
Rv0410c_2pzi_A93ri5_IVM_A_349PDBCREDO0.6890.0900.5190.008
Rv0410c_2pzi_A93d91_REM_B_350PDBCREDO0.6450.1300.5180.008
Rv0410c.2123d91_REM_A_350PDBCREDO0.5330.2680.5180.008
Rv0410c.2401e7b_HLT_A_4003PDBCREDO0.7000.0810.5170.008
Rv0410c.1413f78_ICF_A_1PDBCREDO0.5500.2430.5170.008
Rv0410c.2122jfa_RAL_A_600PDBCREDO0.5670.2210.5170.008
Rv0410c.2404dtz_LDP_A_501PDBCREDO0.5170.2930.5170.008
Rv0410c.1101err_RAL_A_600PDBCREDO0.5820.2010.5160.009
Rv0410c_2pzi_A24eyb_0WO_A_303PDBCREDO0.5530.2390.5160.009
Rv0410c_2pzi_A93rhw_IVM_A_348PDBCREDO0.6850.0930.5160.009
Rv0410c_2pzi_A93ria_IVM_E_349PDBCREDO0.6850.0930.5160.009
Rv0410c.251lhv_NOG_A_301PDBCREDO0.6560.1190.5150.009
Rv0410c.2122jfa_RAL_B_600PDBCREDO0.5470.2480.5150.009
Rv0410c.1102jfa_RAL_B_600PDBCREDO0.5800.2030.5140.009
Rv0410c.1121jzs_MRC_A_1301PDBCREDO0.5340.2670.5140.009
Rv0410c.2123spk_TPV_B_100PDBCREDO0.5450.2510.5140.009
Rv0410c.252w8y_486_A_1000PDBCREDO0.5600.2300.5130.009
Rv0410c.1103b0w_DGX_A_1PDBCREDO0.5290.2750.5130.009
Rv0410c.251tco_FK5_C_509PDBCREDO0.6360.1390.5130.009
Rv0410c_2pzi_A91ict_T44_D_129PDBCREDO0.7360.0560.5130.009
Rv0410c_2pzi_A22fum_MIX_D_3539PDBCREDO0.5130.2990.5130.009
Rv0410c_2pzi_A23k2h_LYA_B_514PDBCREDO0.5490.2450.5130.009
Rv0410c.1103heg_BAX_A_1PDBCREDO0.5440.2530.5120.009
Rv0410c.252oiq_STI_A_1001PDBCREDO0.5760.2090.5120.009
Rv0410c.252x9g_LYA_B_1270PDBCREDO0.7190.0670.5120.009
Rv0410c.253tne_RIT_B_401PDBCREDO0.6310.1430.5120.009
Rv0410c.1412y7w_SAL_A_1300PDBCREDO0.5440.2530.5120.009
Rv0410c.2121err_RAL_A_600PDBCREDO0.5440.2530.5120.009
Rv0410c.2121err_RAL_B_600PDBCREDO0.5440.2530.5120.009
Rv0410c.1101tco_FK5_C_509PDBCREDO0.6720.1040.5120.009
Rv0410c.1411ikv_EFZ_A_2000PDBCREDO0.7180.0680.5110.009
Rv0410c.1103b0w_DGX_B_1PDBCREDO0.5570.2350.5110.009
Rv0410c_2pzi_A92c49_ADN_A_1301PDBCREDO0.7040.0780.5100.009
Rv0410c.2123ln1_CEL_C_682PDBCREDO0.5950.1840.5090.009
Rv0410c.2123ut5_LOC_B_502PDBCREDO0.5250.2800.5090.009
Rv0410c_2pzi_A24eyb_0WO_B_301PDBCREDO0.5870.1950.5090.009
Rv0410c.2123ln1_CEL_A_682PDBCREDO0.5950.1850.5090.010
Rv0410c_2pzi_A93f4x_KLT_A_300PDBCREDO0.6760.1010.5090.010
Rv0410c_2pzi_A93frq_ERY_A_195PDBCREDO0.6520.1230.5090.010
Rv0410c.2123ln1_CEL_B_682PDBCREDO0.5940.1860.5080.010
Rv0410c.2121zgy_BRL_A_503PDBCREDO0.6340.1400.5080.010
Rv0410c.2123qt0_486_A_4PDBCREDO0.6560.1190.5070.010
Rv0410c.2402wek_DIF_A_1375PDBCREDO0.5070.3080.5070.010
Rv0410c_2pzi_A91cil_ETS_A_263PDBCREDO0.5420.2560.5070.010
Rv0410c_2pzi_A93ri5_IVM_E_349PDBCREDO0.7270.0620.5070.010
Rv0410c.1124eyb_0WO_B_301PDBCREDO0.5260.2790.5060.010
Rv0410c.2123k5v_STI_A_2PDBCREDO0.5850.1970.5060.010
Rv0410c.2121opj_STI_A_3PDBCREDO0.6010.1780.5060.010
Rv0410c.2123oht_1N1_B_1000PDBCREDO0.7000.0810.5050.010
Rv0410c.1102w8y_486_A_1000PDBCREDO0.5200.2870.5050.010
Rv0410c_2pzi_A92oax_SNL_C_3001PDBCREDO0.5560.2350.5050.010
Rv0410c.2401e7b_HLT_B_4003PDBCREDO0.6830.0940.5050.010
Rv0410c.2123bbt_FMM_D_91PDBCREDO0.6520.1220.5050.010
Rv0410c.2404a9j_TYL_C_1184PDBCREDO0.5470.2490.5050.010
Rv0410c.251xkk_FMM_A_91PDBCREDO0.6100.1680.5040.010
Rv0410c_2pzi_A93mne_DEX_A_784PDBCREDO0.5210.2860.5040.010
Rv0410c_2pzi_A93vhu_SNL_A_1001PDBCREDO0.5560.2360.5040.010
Rv0410c_2pzi_A22ya7_ZMR_D_1776PDBCREDO0.5600.2300.5040.010
Rv0410c.1102x9g_LYA_A_1270PDBCREDO0.6060.1720.5040.010
Rv0410c_2pzi_A93gn8_DEX_B_247PDBCREDO0.5210.2860.5040.010
Rv0410c_2pzi_A92ab2_SNL_A_502PDBCREDO0.5550.2380.5030.010
Rv0410c.2404du2_LDP_A_501PDBCREDO0.5030.3130.5030.010
Rv0410c.2123q70_RIT_A_2001PDBCREDO0.5030.3140.5030.010
Rv0410c.2123vn2_TLS_A_501PDBCREDO0.5350.2660.5030.010
Rv0410c_2pzi_A91z2b_VLB_C_800PDBCREDO0.6080.1700.5030.010
Rv0410c.2123spk_TPV_A_100PDBCREDO0.6280.1470.5020.011
Rv0410c_2pzi_A92oax_SNL_B_2001PDBCREDO0.5540.2390.5020.011
Rv0410c_2pzi_A92aa6_STR_A_401PDBCREDO0.5020.3150.5020.011
Rv0410c_2pzi_A22zi9_CL9_A_401PDBCREDO0.5780.2060.5020.011
Rv0410c_2pzi_A92ab2_SNL_B_503PDBCREDO0.5530.2400.5020.011
Rv0410c.252gqg_1N1_B_502PDBCREDO0.6810.0960.5020.011
Rv0410c.1121d4f_ADN_D_604PDBCREDO0.5020.3160.5020.011
Rv0410c.1102jfa_RAL_A_600PDBCREDO0.5840.1990.5020.011
Rv0410c.2122nni_MTK_A_501PDBCREDO0.5320.2690.5020.011
Rv0410c.2122qxs_RAL_A_600PDBCREDO0.6130.1640.5020.011
Rv0410c_2pzi_A91fr6_AZR_A_362PDBCREDO0.6660.1090.5020.011
Rv0410c_2pzi_A91p93_DEX_D_4999PDBCREDO0.5180.2910.5010.011
Rv0410c.2123h52_486_B_1PDBCREDO0.5010.3170.5010.011
Rv0410c.2123v5w_8PR_A_701PDBCREDO0.5860.1960.5010.011
Rv0410c_2pzi_A91p93_DEX_C_3999PDBCREDO0.5170.2910.5010.011
Rv0410c.2123oct_1N1_A_663PDBCREDO0.6700.1060.5010.011
Rv0410c_2pzi_A92aax_PDN_A_502PDBCREDO0.5010.3180.5010.011
Similarity to known drug target from sensitive sequence analysis
No drug targets
List of small molecules tested from TIBLE
  View results in TIBLE page
NameAffinityAssay descriptionDOI
CHEMBL2017707ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017708ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017709ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017710ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017711ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017712ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017713ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017714ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017715ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017716ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017717ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017718ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017719ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017720ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017721ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017722ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017723ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017724ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017725ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017726ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017727ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017728ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017729ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017730ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017731ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017732ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017733ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017734ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017735ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017736ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017737ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017738ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017739ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017870ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2017871ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
CHEMBL2070289Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070289Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 6.25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070289Inhibition = 13 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 50 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070289Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 12.5 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070289Inhibition = 23 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 100 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070289Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 3.125 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070290Inhibition = 43 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 100 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070290Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 6.25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070290Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 3.125 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070290Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070290Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 50 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070291Inhibition = 11 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 100 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070292Inhibition = 4 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 100 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070293Inhibition = 5 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 100 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070294Inhibition = 17 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 100 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070295Inhibition = 11 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 100 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070296Inhibition = 37 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 50 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070296Inhibition = 14 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070296Inhibition = 5 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 3.125 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070296Inhibition = 18 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 12.5 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070296Inhibition = 4 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 6.25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070296Inhibition = 29 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 100 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070297Inhibition = 5 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 6.25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070297Inhibition = 5 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 12.5 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070297Inhibition = 53 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 100 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070297Inhibition = 4 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 3.125 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070297Inhibition = 19 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070298Inhibition = 12 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 100 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070299Inhibition = 43 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 100 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070299Inhibition = 10 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 12.5 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070299Inhibition = 6 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 3.125 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070299Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 6.25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070299Inhibition = 9 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070299Inhibition = 43 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 50 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070300Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070300Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 12.5 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070300Inhibition = 28 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 100 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070300Inhibition = 16 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 50 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070300Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 6.25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070300Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 3.125 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070301Inhibition = 35 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 100 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070301Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 3.125 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070301Inhibition = 7 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070301Inhibition = 11 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 12.5 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070301Inhibition = 9 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 6.25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070301Inhibition = 25 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 50 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070302Inhibition = 9 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070302Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 12.5 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070302Inhibition = 17 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 50 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070302Inhibition = 41 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 100 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070303Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 50 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070303Inhibition = 5 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 3.125 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070303Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070303Inhibition = 19 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 100 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070303Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 12.5 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070303Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 6.25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070304Inhibition = 5 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 100 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070305Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 12.5 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070305Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070305Inhibition = 2 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 6.25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070305Inhibition = 34 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 100 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070305Inhibition = 0 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 3.125 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070305Inhibition = 3 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 50 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070306Inhibition = 12 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 12.5 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070306Inhibition = 38 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 100 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070306Inhibition = 24 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 50 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL2070306Inhibition = 22 %Inhibition of Mycobacterium tuberculosis recombinant PKnG expressed in Escherichia coli BL21 (DE3) cells using myelin basic protein substrate at 25 uM by luciferase activity based ADP-Glo-luminescent kinase assayhttp://www.ncbi.nlm.nih.gov/pubmed/22854194
CHEMBL379367ActiveInhibition of Mycobacterium tuberculosis Protein kinase G by radiometric ATP consumptive assayhttp://www.ncbi.nlm.nih.gov/pubmed/17616581
CHEMBL549536ActiveInhibition of Mycobacterium tuberculosis PknGhttp://www.ncbi.nlm.nih.gov/pubmed/22469702
Off-target activity - ligand based from TIBLE
  View results in TIBLE page
Predicted off-targetMethodSummaryFull results
None Noneno_bindLink
Small molecules involved in protein-protein complex from TIMBAL .Proteins similar to Mtb based on sequence analysis.
Target nameCHEMBL IDSMILES
Plk1(PBD)CC(C)C1=CC(=O)C(C)=CC1=O
Plk1(PBD)CC(C)C1=CC(=N/O)C(C)=CC1=O
STITCH interactions  
Chemical NameConfidence scoreMolecular Weight
AxxPubChem0.979264.343
chloridePubChem0.935.453
cadmiumPubChem0.9232.515
glycerolPubChem0.992.0938